The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis
- PMID: 2647862
- DOI: 10.1093/infdis/159.4.725
The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis
Abstract
Multivariate analyses of clinical presentation, subspecies identity of the causal organism, and the Leishmania-specific immune response parameters (indirect fluorescent antibody test [IFAT], cutaneous delayed type hypersensitivity [DTH], and in vitro lymphocyte transformation [LT]) of 441 patients with tegumentary leishmaniasis were used to examine the human host-parasite interaction in L. braziliensis infection. Mucocutaneous disease (P less than .002) and L. braziliensis braziliensis infection (P less than .001) were independently associated with significantly higher IFAT titers and cutaneous DTH than were cutaneous disease or L. braziliensis panamensis infection. Lesion size was also correlated with IFAT titer (P. less than .001). Although time of lesion evolution was highly correlated with all parameters, differences associated with subspecies and disease form were independent of lesion duration (three-way analysis of variance). In contrast with the cutaneous DTH response, the in vitro lymphocyte proliferative response to Leishmania antigen did not correlate with disease form and only weakly with infecting subspecies when time of evolution and subspecies were controlled. The association of mucosal disease presentation with a particular subspecies and the independent correlation of both variables with heightened IFAT titers and cutaneous DTH to Leishmania antigen supports the possibility of immune mechanisms of pathogenesis in human tegumentary leishmaniasis.
Similar articles
-
Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.Clin Vaccine Immunol. 2007 Sep;14(9):1173-81. doi: 10.1128/CVI.00060-07. Epub 2007 Jul 11. Clin Vaccine Immunol. 2007. PMID: 17626159 Free PMC article.
-
Humoral immune responses among mucosal and cutaneous leishmaniasis patients caused by Leishmania braziliensis.J Parasitol. 1999 Dec;85(6):1076-83. J Parasitol. 1999. PMID: 10647040
-
Analysis of the specificity of human antibodies to antigens of Leishmania braziliensis braziliensis.Rev Inst Med Trop Sao Paulo. 1989 Jul-Aug;31(4):228-34. doi: 10.1590/s0036-46651989000400004. Rev Inst Med Trop Sao Paulo. 1989. PMID: 2626643
-
The Paradox of a Phagosomal Lifestyle: How Innate Host Cell-Leishmania amazonensis Interactions Lead to a Progressive Chronic Disease.Front Immunol. 2021 Sep 7;12:728848. doi: 10.3389/fimmu.2021.728848. eCollection 2021. Front Immunol. 2021. PMID: 34557194 Free PMC article. Review.
-
Serodiagnosis of leishmaniasis.Crit Rev Microbiol. 1995;21(2):123-52. doi: 10.3109/10408419509113537. Crit Rev Microbiol. 1995. PMID: 7639932 Review.
Cited by
-
Leishmania braziliensis-reactive T cells are down-regulated in long-term cured cutaneous Leishmaniasis, but the renewal capacity of T effector memory compartments is preserved.PLoS One. 2013 Nov 26;8(11):e81529. doi: 10.1371/journal.pone.0081529. eCollection 2013. PLoS One. 2013. PMID: 24303052 Free PMC article.
-
Comparative analysis of the nitric oxide production by Leishmania sp.Med Microbiol Immunol. 2003 Nov;192(4):217-23. doi: 10.1007/s00430-003-0176-z. Epub 2003 Jun 21. Med Microbiol Immunol. 2003. PMID: 12827512
-
Profiles of Local and Systemic Inflammation in the Outcome of Treatment of Human Cutaneous Leishmaniasis Caused by Leishmania (Viannia).Infect Immun. 2020 Feb 20;88(3):e00764-19. doi: 10.1128/IAI.00764-19. Print 2020 Feb 20. Infect Immun. 2020. PMID: 31818959 Free PMC article.
-
Early Leukocyte Responses in Ex-Vivo Models of Healing and Non-Healing Human Leishmania (Viannia) panamensis Infections.Front Cell Infect Microbiol. 2021 Sep 7;11:687607. doi: 10.3389/fcimb.2021.687607. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34557423 Free PMC article.
-
T-cell-mediated immune responses in patients with cutaneous or mucosal leishmaniasis: long-term evaluation after therapy.Clin Diagn Lab Immunol. 2002 Mar;9(2):251-6. doi: 10.1128/cdli.9.2.251-256.2002. Clin Diagn Lab Immunol. 2002. PMID: 11874860 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical